Finland, UK and Netherlands: a new theranostic based on actiniun 225 for metastatic prostate cancer
A Phase 1 Open-label trial of Actiniu... - Advanced Prostate...
A Phase 1 Open-label trial of Actinium-225-macropa-pelgifatamab for Advanced Metastatic Castration Resistant Prostate Cancer (mCRPC)
Written by
Maxone73
To view profiles and participate in discussions please or .
Read more about...
2 Replies
•
This is the UK trial:bepartofresearch.nihr.ac.uk...
Not what you're looking for?
You may also like...
Syncromune Granted FDA Fast-Track Designation for SYNC-T SV-102 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
FORT LAUDERDALE, Fla., July 01, 2024 (GLOBE NEWSWIRE) -- Syncromune® Inc., a clinical-stage...
Treatment After Progression in Metastatic Castration-Resistant Prostate Cancer: some options
Interesting perspective, but we need more weapons still!...
PTEN loss is not a determinant of time to castration-resistance following androgen-deprivation therapy in prostate cancer
Abdallah Alzoubi 1 2 , Samir Al Bashir 3 , Aya Smairat 4 , Ahmad Alrawashdeh 5 , Husam...
177Lu-PNT2002 Significantly Improves rPFS Vs ARPI in Metastatic Castration-Resistant Prostate Cancer
https://www.onclive.com/view/177lu-pnt2002-significantly-improves-rpfs-vs-arpi-in-metastatic-castrat
Lu-177-PSMA-I&T for low volume Metastatic Castration-Resistant Prostate Cancer
I've heard they've been doing this in Germany recently. Is anyone familiar with Lu-177-PSMA-I&T for...
Related Posts
- Title :Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer
FDA Grants Fast Track Designation for 177Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer
New study on the value of EXERCISE for advanced prostate cancer 
Is it useful to get a PSMA-PET scan with low volume cancer, newly castration resistant and PSA below 1?
225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer
